|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C12N 15/13 | |||
| C12N 15/63 | |||
| A61P 35/00 | |||
| C07K 16/32 | |||
| A61K 39/00 | |||
| C07K 16/30 |
| (11) | Number of the document | 2540745 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10846324.1 |
| Date of filing the European patent application | 2010-04-16 | |
| (97) | Date of publication of the European application | 2013-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2010/000511 |
| Date | 2010-04-16 |
| (87) | Number | WO 2011/103700 |
| Date | 2011-09-01 |
| (30) | Number | Date | Country code |
| 201010125241 | 2010-02-25 | CN |
| (72) |
LI, Chuan, CN
TONG, Xin, CN
KAN, Ying, CN
|
| (73) |
Shanghai Biomabs Pharmaceuticals Co., Ltd,
No. 301, Libing Road, Pudong District Shanghai 201203,
CN
|
| (54) | FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF |
| FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF |